array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(29) "Tekla Life Sciences Investors"
["slug"]=>
string(38) "30be8-us-tekla-life-sciences-investors"
["logo"]=>
NULL
["description"]=>
string(523) "Tekla Life Sciences Investors (HQL) is a non-diversified closed-end healthcare fund that primarily invests in the life sciences industry. The fund aims to provide long-term capital appreciation through investments in companies in the life sciences industry with potential for above-average long-term growth. It focuses on smaller, emerging companies and may invest up to 40% of its assets in restricted securities of both public and private companies. The fund is traded on the New York Stock Exchange under the ticker HQL."
["address_street"]=>
string(17) "2 Liberty Sq FL 9"
["address_place"]=>
string(6) "Boston"
["address_region"]=>
string(13) "Massachusetts"
["founding_date"]=>
string(10) "2000-01-26"
["website_domain"]=>
string(12) "teklacap.com"
["website_url"]=>
string(24) "https://www.teklacap.com"
["industry_codes"]=>
array(1) {
[0]=>
string(39) "Management Investment Offices, Open-End"
}
["employee_count"]=>
int(7)
["article_count"]=>
int(78)
}
["articles"]=>
array(6) {
[0]=>
array(7) {
["title_en"]=>
string(84) "Johnson & Johnson (NYSE:JNJ) Stock Position Raised by Graham Capital Management L.P."
["snippet_en"]=>
string(296) "Graham Capital Management L.P. raised its stake in Johnson & Johnson (NYSE:JNJ - Free Report) by 108.3% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 108,569 shares of the company's stock after acquiring a"
["url"]=>
string(73) "https://www.marketbeat.com/instant-alerts/nyse-jnj-sec-filing-2023-11-30/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/3002266e-8d28-47bf-a243-7dc9f574377a"
["source"]=>
string(14) "marketbeat.com"
["publication_date"]=>
string(10) "2023-11-30"
["categories"]=>
array(8) {
[0]=>
string(24) "Quarterly/Annual Figures"
[1]=>
string(16) "Share Repurchase"
[2]=>
string(18) "General Investment"
[3]=>
string(14) "Issuing Shares"
[4]=>
string(12) "Stock Market"
[5]=>
string(31) "Financial Update/Profit Warning"
[6]=>
string(20) "Corporate Governance"
[7]=>
string(11) "Acquisition"
}
}
[1]=>
array(7) {
["title_en"]=>
string(72) "Johnson & Johnson (NYSE:JNJ) Shares Bought by RNC Capital Management LLC"
["snippet_en"]=>
string(217) "RNC Capital Management LLC raised its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 0.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC)."
["url"]=>
string(112) "https://www.defenseworld.net/2023/10/09/johnson-johnson-nysejnj-shares-bought-by-rnc-capital-management-llc.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/541f0636-9fd8-491d-8e1a-8da06ab1b9dc"
["source"]=>
string(16) "defenseworld.net"
["publication_date"]=>
string(10) "2023-10-09"
["categories"]=>
array(9) {
[0]=>
string(24) "Quarterly/Annual Figures"
[1]=>
string(16) "Share Repurchase"
[2]=>
string(11) "Regulations"
[3]=>
string(18) "General Investment"
[4]=>
string(14) "Issuing Shares"
[5]=>
string(18) "Expansion & Growth"
[6]=>
string(12) "Stock Market"
[7]=>
string(31) "Financial Update/Profit Warning"
[8]=>
string(11) "Acquisition"
}
}
[2]=>
array(7) {
["title_en"]=>
string(82) "Lbmc Investment Advisors LLC Acquires 1,287 Shares of Johnson & Johnson (NYSE:JNJ)"
["snippet_en"]=>
string(300) "Lbmc Investment Advisors LLC grew its holdings in Johnson & Johnson (NYSE:JNJ - Free Report) by 21.4% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 7,294 shares of the company's stock after purchasing an additional 1,287 s"
["url"]=>
string(73) "https://www.marketbeat.com/instant-alerts/nyse-jnj-sec-filing-2023-09-29/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/28564341-88d3-4b88-b2ed-9009ed96617e"
["source"]=>
string(14) "marketbeat.com"
["publication_date"]=>
string(10) "2023-09-29"
["categories"]=>
array(10) {
[0]=>
string(24) "Stock Research & Ratings"
[1]=>
string(24) "Quarterly/Annual Figures"
[2]=>
string(16) "Share Repurchase"
[3]=>
string(11) "Regulations"
[4]=>
string(18) "General Investment"
[5]=>
string(14) "Issuing Shares"
[6]=>
string(19) "Investment Requests"
[7]=>
string(12) "Stock Market"
[8]=>
string(31) "Financial Update/Profit Warning"
[9]=>
string(11) "Acquisition"
}
}
[3]=>
array(7) {
["title_en"]=>
string(70) "Tekla Funds Approve New Investment Advisory Agreements With abrdn Inc."
["snippet_en"]=>
string(190) "Tekla Capital Management LLC announced today that the requisite vote has been attained to approve the new investment advisory agreement with abrdn Inc. for each of its four closed-end funds."
["url"]=>
string(118) "https://www.nasdaq.com/press-release/tekla-funds-approve-new-investment-advisory-agreements-with-abrdn-inc.-2023-10-27"
["image_url"]=>
NULL
["source"]=>
string(10) "nasdaq.com"
["publication_date"]=>
string(10) "2023-06-30"
["categories"]=>
array(5) {
[0]=>
string(25) "Business Model Resilience"
[1]=>
string(18) "General Investment"
[2]=>
string(15) "Deals & Tenders"
[3]=>
string(13) "Collaboration"
[4]=>
string(19) "Investment Requests"
}
}
[4]=>
array(7) {
["title_en"]=>
string(78) "abrdn to Acquire US Specialist Healthcare Closed-End Funds with $3 Billion AUM"
["snippet_en"]=>
string(269) "abrdn plc today announced that its U.S. subsidiary abrdn Inc. has entered into an agreement to acquire the healthcare fund management capabilities of Tekla Capital Management LLC (Tekla), a global specialist healthcare investment adviser based in Boston, Massachusetts."
["url"]=>
string(84) "https://finance.yahoo.com/news/abrdn-acquire-us-specialist-healthcare-221500989.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/965c9901-84c5-4864-8fbd-8c2564370b75"
["source"]=>
string(9) "yahoo.com"
["publication_date"]=>
string(10) "2023-06-20"
["categories"]=>
array(3) {
[0]=>
string(25) "Business Model Resilience"
[1]=>
string(11) "Acquisition"
[2]=>
string(18) "General Investment"
}
}
[5]=>
array(7) {
["title_en"]=>
string(57) "Tekla Life Sciences Investors Declares Stock Distribution"
["snippet_en"]=>
string(271) "On November 15, 2019, Tekla Life Sciences Investors declared a stock distribution of $0.33 per share. Written notification for the election of cash instead of stock by registered shareholders must be received by Computershare Investor Services prior to December 23, 2019."
["url"]=>
string(101) "https://nasdaq.com/press-release/tekla-life-sciences-investors-declares-stock-distribution-2019-11-15"
["image_url"]=>
NULL
["source"]=>
string(10) "nasdaq.com"
["publication_date"]=>
NULL
["categories"]=>
array(4) {
[0]=>
string(21) "Shareholders Feedback"
[1]=>
string(12) "Stock Market"
[2]=>
string(9) "Investors"
[3]=>
string(18) "General Investment"
}
}
}
["category_annotations"]=>
array(22) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(16)
}
[1]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(6)
}
[2]=>
array(2) {
["name"]=>
string(10) "Tax Havens"
["count"]=>
int(6)
}
[3]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(5)
}
[4]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(4)
}
[5]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(4)
}
[6]=>
array(2) {
["name"]=>
string(21) "Shareholders Feedback"
["count"]=>
int(4)
}
[7]=>
array(2) {
["name"]=>
string(16) "Share Repurchase"
["count"]=>
int(4)
}
[8]=>
array(2) {
["name"]=>
string(10) "Divestment"
["count"]=>
int(3)
}
[9]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(2)
}
[10]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(2)
}
[11]=>
array(2) {
["name"]=>
string(11) "Regulations"
["count"]=>
int(2)
}
[12]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(2)
}
[13]=>
array(2) {
["name"]=>
string(22) "Business Restructuring"
["count"]=>
int(2)
}
[14]=>
array(2) {
["name"]=>
string(20) "Corporate Governance"
["count"]=>
int(2)
}
[15]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(1)
}
[16]=>
array(2) {
["name"]=>
string(23) "Supply Chain Management"
["count"]=>
int(1)
}
[17]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(1)
}
[18]=>
array(2) {
["name"]=>
string(12) "Going Public"
["count"]=>
int(1)
}
[19]=>
array(2) {
["name"]=>
string(19) "Investment Requests"
["count"]=>
int(1)
}
[20]=>
array(2) {
["name"]=>
string(9) "Investors"
["count"]=>
int(1)
}
[21]=>
array(2) {
["name"]=>
string(20) "Business Development"
["count"]=>
int(1)
}
}
}
30be8-us-tekla-life-sciences-investors
Tekla Life Sciences Investors
Tekla Life Sciences Investors
Location
Massachusetts
Founded
2000-01-26
Website
https://www.teklacap.com
Articles
78 Articles
Category
Management Investment Offices, Open-End
Description
Tekla Life Sciences Investors (HQL) is a non-diversified closed-end healthcare fund that primarily invests in the life sciences industry. The fund aims to provide long-term capital appreciation through investments in companies in the life sciences industry with potential for above-average long-term growth. It focuses on smaller, emerging companies and may invest up to 40% of its assets in restricted securities of both public and private companies. The fund is traded on the New York Stock Exchange under the ticker HQL.
Graham Capital Management L.P. raised its stake in Johnson & Johnson (NYSE:JNJ - Free Report) by 108.3% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 108,569 shares of the company's stock after acquiring a
RNC Capital Management LLC raised its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 0.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).
Lbmc Investment Advisors LLC grew its holdings in Johnson & Johnson (NYSE:JNJ - Free Report) by 21.4% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 7,294 shares of the company's stock after purchasing an additional 1,287 s
Tekla Capital Management LLC announced today that the requisite vote has been attained to approve the new investment advisory agreement with abrdn Inc. for each of its four closed-end funds.
abrdn plc today announced that its U.S. subsidiary abrdn Inc. has entered into an agreement to acquire the healthcare fund management capabilities of Tekla Capital Management LLC (Tekla), a global specialist healthcare investment adviser based in Boston, Massachusetts.
On November 15, 2019, Tekla Life Sciences Investors declared a stock distribution of $0.33 per share. Written notification for the election of cash instead of stock by registered shareholders must be received by Computershare Investor Services prior to December 23, 2019.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
